North America
A workshop co-hosted by the US FDA and Duke on ideas to expand access to epinephrine for anaphylaxis is the latest example of the agency holding a public meeting that could have been an advisory committee – but without the formalities.
Some FDA employees who were recently laid off by the Trump Administration are being called back to work, multiple sources confirmed to the Pink Sheet.
Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.
Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.
Latin America
GSCF, AESGP and ILAR agree that 2026 will see self‑care translate into more tangible system‑level action, propelled by prevention, regulatory updates and more assertive efforts to counter misleading claims.
The South African Health Products Regulatory Authority is calling on manufacturers of food supplements marketed for children containing zinc picolinate and/or selenium to withdraw these products from the market within six months of the notice.
Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.
OTC private label/store brand product giant’s Q2 net sales down 10.7% to $1.1bn, but women’s health product sales jump 31.4% largely on Opill launched late in Q1. Biggest hit to results from infant formula business, down a reported 82% due to ongoing manufacturing quality-control remediation.
Europe
Umbrella branding in OTC medicines supports responsible self‑care by helping consumers navigate choices, build trust and confidence, and access reliable health information, countering regulators’ long‑standing focus on risks rather than benefits, says PAGB CEO Michelle Riddalls.
Industry associations in the UK, Germany and Greece expect 2026 to be the year self‑care policy is translated into day‑to‑day system change. They highlight opportunities in pharmacy, digital tools and regulatory reform, but warn that progress depends on political timing and regulatory agility.
GSCF, AESGP and ILAR agree that 2026 will see self‑care translate into more tangible system‑level action, propelled by prevention, regulatory updates and more assertive efforts to counter misleading claims.
Consumer health companies can help accelerate the shift to prevention as employers and through innovation and cross-sector partnerships, unlocking a potential £42bn in savings for the UK National Health Service.
Asia
Huge opportunities for OTC therapies loom in India, as consumerization brings structural reset in healthcare. Success stories on Rx-to-OTC transition augur well for pharma, but a predictable regulatory roadmap will be pivotal for sustainable growth.
Reckitt's leadership discussed the company's growth strategy for emerging markets at a recent meeting for analysts.
Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.
HBW Insight speaks to Opella's Asia Pacific, Middle East and Africa (AMEA) head, Carol-Anne Stewart, about the company's China growth strategy in this exclusive interview.
International
GSCF, AESGP and ILAR agree that 2026 will see self‑care translate into more tangible system‑level action, propelled by prevention, regulatory updates and more assertive efforts to counter misleading claims.
The global allergy market is “expanding again but on new terms, driven by a mix of regional strength, evolving consumer behaviors, and an increasingly diverse competitive field,” according to the latest IQVIA Consumer Health analysis.
The United for Self-Care Coalition publishes a manifesto that it hopes will accelerate the UN’s vision set out in a recent political declaration that aims to prevent and control non-communicable diseases and promote mental health and wellbeing.
A recent Deloitte survey found that women are emerging as the “chief health officers” of everyday life, younger consumers are something of an enigma, being both adventurous and skeptical, and attitudes to health technologies vary geographically.
















